Aprepitant Capsules and Trastuzumab and Hyaluronidase
Determining the interaction of Aprepitant Capsules and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Trastuzumab Injection (Intravenous)
- Aprepitant Capsules-Trastuzumab Intravenous
- Aprepitant Capsules-Trastuzumab-anns
- Aprepitant Capsules-Trastuzumab-dkst
- Aprepitant Capsules-Trastuzumab-dkst Intravenous
- Aprepitant Capsules-Trasylol
- Trastuzumab and Hyaluronidase-Aprepitant Injection
- Trastuzumab and Hyaluronidase-Aprepitant Intravenous
- Trastuzumab and Hyaluronidase-Aprepitant Oral Suspension
- Trastuzumab and Hyaluronidase-Aprepitant/Fosaprepitant Dimeglumine
- Trastuzumab and Hyaluronidase-Apresazide
- Trastuzumab and Hyaluronidase-Apresoline